Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
89bio stock falls following public offering announcement
Shares of 89bio, Inc. (NASDAQ:ETNB) tumbled 6% after the company announced its plans for an underwritten public offering of common stock and pre-funded warrants. The clinical-stage biopharmaceutical company,
Evaxion announces pricing of $10.8 million public offering
MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, who became an Evaxion shareholder in December 2023, is also participating in this offering along with healthcare-focused investment funds. There is also participation from Evaxion’s Board of Directors and Management.
Atlas Energy Solutions Announces Pricing of Upsized Underwritten Public Offering of Common Stock
Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer
Immunome stock tumbles after public offering pricing
Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company, known for its work on targeted cancer therapies,
Metsera Announces Pricing of Initial Public Offering
A registration statement on Form S-1 (File No. 333-284225) relating to the offering has been filed with the Securities and Exchange Commission and became effective on January 30, 2025. The offering is being made only by means of a prospectus.
Butterfly Network Announces Proposed Public Offering of Common Stock
TD Cowen, William Blair and Lake Street Capital Markets are the bookrunners for the proposed offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering.
Butterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ult
Sunrise Realty Trust prices upsized public offering to raise ~$69M
Mortgage REIT Sunrise Realty Trust (SUNS) announced on Tuesday the pricing of an upsized underwritten public offering of 5.75M shares of common stock at $12.00 per share for gross proceeds of ~$69M.
Beta Bionics Goes Public After Raising $204M Upsized Offering
Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours of trading.
Decent Holding Inc. Announces Pricing of Initial Public Offering
Decent Holding Inc. (the “Company”), an established wastewater treatment services provider in China, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.
4d
When Did Facebook (Meta) Go Public?
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
8d
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is ...
Hosted on MSN
7h
Wearable Devices Ltd. Completes $2.5 Million Public Offering
Wearable Devices Ltd. ( ($WLDS) ) has provided an update. On January 30, 2025, Wearable Devices Ltd. announced the successful closing of a $2.5 ...
19h
on MSN
Elicio Therapeutics secures $10 million in direct offering
BOSTON - Elicio Therapeutics , Inc. (NASDAQ:ELTX), a clinical-stage biotech company focusing on cancer immunotherapies, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback